Associate professor Hollande will discuss the main challenges and issues in identifying, detecting, studying and targeting cell subsets and how through intensive characterisation of cellular and molecular processes that drive cancer cell behaviour, we are making improvements in treating tumours, but also unravelling unexpected complexities.
Associate Professor Frederic Hollande
Associate Professor Frederic Hollande obtained his PhD in 1994 from the University of Montpellier, France. He then worked as a post-doctoral research fellow at the Ludwig Institute for Cancer Research and the University of Melbourne (1994-1996), and has worked as a CNRS Research Fellow in France since 1996 to study molecular mechanisms that underlie the progression of colon cancer. Associate Professor Hollande has been a senior Research Fellow since 2009 and Head of the Oncology Research Department at the Institute of Functional Genomics of Montpellier (2011-2012). In parallel with his academic work he co-founded in 2007 a small biotech company developing therapeutic monoclonal antibodies. He was the joint-scientific director of this company and designed its intellectual property portfolio. The company was acquired by the French Pharmaceutical company Servier in June 2011.
Associate Professor Hollande moved to Melbourne in September 2012 to take up a position as Associate Professor in the Department of Pathology at the University of Melbourne. He currently is the Deputy Head of Department at the Department of Clinical Pathology. His research interests include the analysis of colorectal cancer stem cell regulation by their surrounding environment, as well as the study of the impact of inter and intra-tumour heterogeneity on metastatic progression and treatment response.
This presentation is relevant to medical practitioners, nurses, researchers, cancer patients and patient groups government health agencies however all are welcome to attend.
Can't attend in person? Register for Webinar